164 related articles for article (PubMed ID: 29162047)
21. Communicating Risks of Adjuvant Chemotherapy for Breast Cancer: Getting Beyond the Laundry List.
Brauer ER; Long EF; Melnikow J; Ravdin PM; Ganz PA
J Oncol Pract; 2019 Feb; 15(2):e98-e109. PubMed ID: 30550372
[TBL] [Abstract][Full Text] [Related]
22. Decision-making on therapeutic futility in Mexican adolescents with cancer: a qualitative study.
Cicero-Oneto CE; Valdez-Martinez E; Bedolla M
BMC Med Ethics; 2017 Dec; 18(1):74. PubMed ID: 29228962
[TBL] [Abstract][Full Text] [Related]
23. A qualitative evaluation of the oncologists', neurologists', and pain specialists' views on the management and care of chemotherapy-induced peripheral neuropathy in The Netherlands.
van Haren FGAM; Steegers MAH; Vissers KCP; van den Heuvel SAS
Support Care Cancer; 2024 Apr; 32(5):301. PubMed ID: 38647694
[TBL] [Abstract][Full Text] [Related]
24. Clinical management of gastric cancer: results of a multicentre survey.
Zhang X; Li N; Wei W; Yao W; Xie K; Hu J; Shen L; Ji W; Lu Y; Wen F; Jiang Y; Xu F; Feng H; Bi F; Li Q;
BMC Cancer; 2011 Aug; 11():369. PubMed ID: 21864355
[TBL] [Abstract][Full Text] [Related]
25. Identification of Educational Gaps Among Oncologists Who Manage Patients with Pancreatic Cancer.
Barnes JA; Ellis ML; Hwang S; Emarine J; Merwin P; Salinas GD; Musher BL
J Gastrointest Cancer; 2019 Mar; 50(1):84-90. PubMed ID: 29177608
[TBL] [Abstract][Full Text] [Related]
26. Discrepancies between medical oncologists and surgeons in assessment of resectability and indication for chemotherapy in patients with colorectal liver metastases.
Homayounfar K; Bleckmann A; Helms HJ; Lordick F; Rüschoff J; Conradi LC; Sprenger T; Ghadimi M; Liersch T
Br J Surg; 2014 Apr; 101(5):550-7. PubMed ID: 24756914
[TBL] [Abstract][Full Text] [Related]
27. Patient autonomy and advance care planning: a qualitative study of oncologist and palliative care physicians' perspectives.
Johnson SB; Butow PN; Kerridge I; Tattersall MHN
Support Care Cancer; 2018 Feb; 26(2):565-574. PubMed ID: 28849351
[TBL] [Abstract][Full Text] [Related]
28. Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.
Choy H; Shyr Y; Cmelak AJ; Mohr PJ; Johnson DH
Cancer; 2000 Mar; 88(6):1336-46. PubMed ID: 10717614
[TBL] [Abstract][Full Text] [Related]
29. Utilization of genomic testing in advanced non-small cell lung cancer among oncologists in the Veterans Health Administration.
Arney J; Helm A; Crook T; Braun UK; Chen GJ; Hayes TG
Lung Cancer; 2018 Feb; 116():25-29. PubMed ID: 29413047
[TBL] [Abstract][Full Text] [Related]
30. What do oncologists say about chemotherapy at the very end of life? Results from a semiqualitative survey.
Behl D; Jatoi A
J Palliat Med; 2010 Jul; 13(7):831-5. PubMed ID: 20636153
[TBL] [Abstract][Full Text] [Related]
31. The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study.
Berry SR; Hubay S; Soibelman H; Martin DK
BMC Health Serv Res; 2007 Nov; 7():193. PubMed ID: 18042302
[TBL] [Abstract][Full Text] [Related]
32. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
[TBL] [Abstract][Full Text] [Related]
33. Chinese oncologists' knowledge, attitudes and practice towards palliative care and end of life issues.
Gu X; Cheng W
BMC Med Educ; 2016 May; 16():149. PubMed ID: 27188161
[TBL] [Abstract][Full Text] [Related]
34. Survey of the Impact of COVID-19 on Oncologists' Decision Making in Cancer.
Ürün Y; Hussain SA; Bakouny Z; Castellano D; Kılıçkap S; Morgan G; Mckay RR; Pels K; Schmidt A; Doroshow DB; Schütz F; Albiges L; Lopes G; Catto JWF; Peters S; Choueiri TK
JCO Glob Oncol; 2020 Aug; 6():1248-1257. PubMed ID: 32755479
[TBL] [Abstract][Full Text] [Related]
35. A qualitative exploration of factors influencing medical staffs' decision-making around nutrition prescription after colorectal surgery.
Rattray M; Roberts S; Desbrow B; Wullschleger M; Robertson T; Hickman I; Marshall AP
BMC Health Serv Res; 2019 Mar; 19(1):178. PubMed ID: 30890125
[TBL] [Abstract][Full Text] [Related]
36. Oncologists' End of Life Treatment Decisions.
Bluhm M; Connell CM; Janz N; Bickel K; DeVries R; Silveira M
J Appl Gerontol; 2017 Apr; 36(4):416-440. PubMed ID: 26198272
[TBL] [Abstract][Full Text] [Related]
37. Decision making in pediatric oncology: Views of parents and physicians in two European countries.
Badarau DO; Ruhe K; Kühne T; De Clercq E; Colita A; Elger BS; Wangmo T
AJOB Empir Bioeth; 2017; 8(1):21-31. PubMed ID: 28949870
[TBL] [Abstract][Full Text] [Related]
38. Implementation of evidence-based knowledge in general practice.
Le JV
Dan Med J; 2017 Dec; 64(12):. PubMed ID: 29206099
[TBL] [Abstract][Full Text] [Related]
39. Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation.
Lau-Min KS; Varughese LA; Nelson MN; Cambareri C; Reddy NJ; Oyer RA; Teitelbaum UR; Tuteja S
BMC Cancer; 2022 Jan; 22(1):47. PubMed ID: 34996412
[TBL] [Abstract][Full Text] [Related]
40. Walking a tightrope: oncologists' perspective on providing information to women with recurrent ovarian cancer (ROC) during the medical encounter.
Elit L; Charles C; Gafni A; Ranford J; Gold ST; Gold I
Support Care Cancer; 2012 Oct; 20(10):2327-33. PubMed ID: 22167296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
